Navigation Links
Death Rates for HIV Patients Decrease Dramatically
Date:7/1/2008

rs for Disease Control and Prevention have more on HIV/AIDS.



SOURCES: Michael Horberg, M.D., director, HIV/AIDS, Kaiser Permanente Health Plan, Santa Clara, Calif.; Srikanth Kolluru, assistant professor, pharmaceutical sciences, Imra Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Kingsville; July 2, 2008, Journal of the American Medical Association


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Stillbirths, infant deaths lead to anxiety, guilt and stress among obstetricians
2. American Lung Association Report Finds Lung Disease Death Rates Increasing While Cancer, Heart Disease and Stroke Death Rates Are Decreasing
3. Arterial Calcium Scans Can Predict Death Risk
4. Healthy Diet Lowers Death Risk for Women
5. Low Vitamin D Could Raise Death Risk
6. Risk of death after cancer diagnosis; shift in stage of breast cancer diagnosis
7. A Cluster of Veterans Deaths; By Fred A. Baughman Jr., MD
8. Worldwide War Deaths Underestimated
9. Crop Workers Have Highest Heat-Related Death Rate
10. Failure to Take Seizure Drugs Boosts Death Risk
11. People With Lower Incomes, Lower Education Levels Have Higher Death Rates After Experiencing Heart Attack
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Death Rates for HIV Patients Decrease Dramatically
Death Rates for HIV Patients Decrease Dramatically
Breaking Medicine Technology:Merieux Alliance Becomes Institut Merieux 2Merieux Alliance Becomes Institut Merieux 3Merieux Alliance Becomes Institut Merieux 4Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Randy Olver Named Emdat CEO Will Lead Next Phase of Growth for Medical Transcription Solutions Provider 60788 1Randy Olver Named Emdat CEO Will Lead Next Phase of Growth for Medical Transcription Solutions Provider 60788 2National Nurse Practitioner Week Recognized by STINSON Brand Innovation With Offer of Notes on Nursing e book 60784 1National Nurse Practitioner Week Recognized by STINSON Brand Innovation With Offer of Notes on Nursing e book 60784 2OncoGenex Reports Third Quarter 2009 Financial Results 14740 1OncoGenex Reports Third Quarter 2009 Financial Results 14740 2OncoGenex Reports Third Quarter 2009 Financial Results 14740 3OncoGenex Reports Third Quarter 2009 Financial Results 14740 4OncoGenex Reports Third Quarter 2009 Financial Results 14740 5OncoGenex Reports Third Quarter 2009 Financial Results 14740 6OncoGenex Reports Third Quarter 2009 Financial Results 14740 7OncoGenex Reports Third Quarter 2009 Financial Results 14740 8